{"url_path":"/sec/tlsiw/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-12","source_url":"https://www.sec.gov/Archives/edgar/data/1826667/0001628280-26-034100-index.html","accession_number":"0001628280-26-034100","cik":"0001826667","ticker":"TLSI","issuer_name":"TriSalus Life Sciences, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1826667/0001628280-26-034100-index.html","primary_entity_key":"0001826667","primary_entity_name":"TriSalus Life Sciences, Inc."},"word_count":371,"has_tables":true,"body_markdown":"Item 6. Exhibits\n\nIncorporated by Reference\n\nExhibitDescription\nSchedule/\n\nForm\nFile NumberExhibitsFiling Date\n\n10.1\n[Fourth](ex101orbimed-trisalusxfour.htm)[Amendment to Credit Agreement by and](ex101orbimed-trisalusxfour.htm)[a](ex101orbimed-trisalusxfour.htm)[mong](ex101orbimed-trisalusxfour.htm)[TriSalus Operating Life Sciences, Inc., TriSalus Life Sciences, Inc. and OrbiMed Royalty & Credit Opportunities IV, LP](ex101orbimed-trisalusxfour.htm)\n\nFiled herewith\n\n19.1\n[TriSalus Life Sciences, Inc.](ex191amendedandrestatedins.htm)[Amended and Restated](ex191amendedandrestatedins.htm)[Insider Trading Policy](ex191amendedandrestatedins.htm)\n\nFiled herewith\n\n31.1\n[Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](ex311ceo302certificationma.htm)\n\nFiled herewith\n\n31.2\n[Certification of the Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](ex312cfo302certificationma.htm)\n\nFiled herewith\n\n32.1*\n\n[Certification of the Principal Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](ex321ceo906certificationma.htm)\n\nFurnished\n\n32.2*\n\n[Certification of the Principal Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](ex322cfo906certificationma.htm)\n\nFurnished\n\n37\n\n[Table](#i7518dd10a2b34b6db57745f9a73f411c_942)[of](#i7518dd10a2b34b6db57745f9a73f411c_942)[Contents](#i7518dd10a2b34b6db57745f9a73f411c_942)\n\nIncorporated by Reference\n\nExhibitDescription\nSchedule/\n\nForm\nFile NumberExhibitsFiling Date\n\n101.INSInline XBRL Instance Document – the instance documents does not appear in the Interactive Data File as its XBRL tags are embedded within the Inline XBRL document.\n\n101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document.\n\n101.SCHInline XBRL Taxonomy Extension Schema Document With Embedded Linkbase Documents.\n\n101.DEFInline XBRL Taxonomy Extension Schema Document.\n\n101.LABInline XBRL Taxonomy Extension Labels Linkbase Document.\n\n101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document.\n\n104Cover Page\n(formatted as Inline XBRL and contained in Exhibit 101)\n\n*\n\nThis certification is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Registrant under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of this Form 10-Q), irrespective of any general incorporation language contained in such filing.\n\n38\n\n[Table](#i7518dd10a2b34b6db57745f9a73f411c_942)[of](#i7518dd10a2b34b6db57745f9a73f411c_942)[Contents](#i7518dd10a2b34b6db57745f9a73f411c_942)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.\n\nTriSalus Life Sciences, Inc.\n\nBy:\n/s/ David Patience\n\nName:\nDavid Patience\n\nTitle:\nChief Financial Officer\n\nDate:\n\nMay 12, 2026\n\n39"}